Professional Seasonal Analysis for Trading

Catalyst Pharmaceuticals, Inc. - Common Stock (CPRX)

Seasonality Analysis

Stocks 20 Years Analyzed

Catalyst Pharmaceuticals, Inc. - Common Stock Annual Seasonality Statistics

36.75%
Avg Annual Return
52.6%
Avg Monthly Win Rate
7/12
Positive Months
20
Years Analyzed

Catalyst Pharmaceuticals, Inc. - Common Stock Monthly Seasonality Performance

Month Avg Return Win Rate Strength
January 2.19%
55%
Moderate
February -1.79%
50%
Weak
March 9.37%
60%
Moderate
April 5.46%
55%
Moderate
May -4.09%
58%
Weak
June 4.21%
58%
Moderate
July 10.74%
58%
Moderate
August BEST 20.81%
63%
Strong
September -0.84%
37%
Very Weak
October WORST -5.98%
47%
Weak
November 0.35%
55%
Moderate
December -3.69%
35%
Very Weak

Catalyst Pharmaceuticals, Inc. - Common Stock 2026 vs Historical Pattern

Current Position
91.06
Historical Avg Position
40.24
Deviation
+50.82
Performance
Significantly Above Average

Catalyst Pharmaceuticals, Inc. - Common Stock Interactive Seasonality Chart

Interactive Seasonality Chart

Unlock the full interactive seasonality chart for CPRX with overlay patterns, custom date ranges, and more.

Create Free Account

Catalyst Pharmaceuticals, Inc. - Common Stock Pattern Scanner

Pattern Scanner

Discover recurring patterns, anomalies, and statistically frequent setups.

Create Free Account

Catalyst Pharmaceuticals, Inc. - Common Stock Seasonal Historical Performance

Historical Performance

See historical average returns for CPRX across multiple timeframes.

Create Free Account

About Catalyst Pharmaceuticals, Inc. - Common Stock (CPRX) Seasonality

Catalyst Pharmaceuticals, Inc. - Common Stock (CPRX) has been analyzed using 20 years of historical data to identify seasonal patterns. Classified under Stocks, Catalyst Pharmaceuticals, Inc. - Common Stock shows distinct seasonal tendencies based on historical data.

The strongest month for Catalyst Pharmaceuticals, Inc. - Common Stock is historically August, with an average return of 20.81% and a win rate of 63%. Conversely, October tends to be the weakest month, averaging -5.98% return.

Looking at the full calendar year, Catalyst Pharmaceuticals, Inc. - Common Stock has an average annual return of 36.75% with an overall monthly win rate of 52.6%. Out of 12 months, 7 typically show positive average returns.

The seasonal pattern for Catalyst Pharmaceuticals, Inc. - Common Stock has a consistency score of 38.9 (Poor), based on 21 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.

Catalyst Pharmaceuticals, Inc. - Common Stock Seasonality FAQ

What is the best month to buy Catalyst Pharmaceuticals, Inc. - Common Stock (CPRX)?

Historically, August has been the best month for Catalyst Pharmaceuticals, Inc. - Common Stock, with an average return of 20.81% and a win rate of 63%. However, past performance does not guarantee future results.

What is the worst month for Catalyst Pharmaceuticals, Inc. - Common Stock (CPRX)?

Based on historical data, October has been the weakest month for Catalyst Pharmaceuticals, Inc. - Common Stock, with an average return of -5.98%. This is a historical observation and does not guarantee future results.

How reliable is CPRX seasonality data?

The seasonality analysis for Catalyst Pharmaceuticals, Inc. - Common Stock is based on 20 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.

How can I use Catalyst Pharmaceuticals, Inc. - Common Stock seasonality in my trading?

Use Catalyst Pharmaceuticals, Inc. - Common Stock (CPRX) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.

More Stocks Seasonality Analysis

Statistical information based on historical data. Does not constitute investment advice or recommendation. Past performance does not guarantee future results.